由法国圣德拉堡（Synthelabo）公司与日 本三菱化学合作率先研制成功。1996年率先在美国上市，临床用于治疗各种过敏反应 性疾病，具有抗组胺和抗过敏性炎症双重...
基于20个网页-相关网页
Sanofi-Synthelabo 拉堡 ; 圣德拉堡 ; 赛诺菲圣德拉堡 ; 赛诺菲圣德拉堡集团
Sanofi-Synthelabo Canada 加拿大赛诺菲圣德拉堡
Synthelabo SA 诺菲圣德拉堡集团
Sanofi-Synthelabo VietNam 生产厂商
And consider that the merger between Sanofi-Synthelabo and Aventis is not yet three years old.
FORBES: Why Bristol And Sanofi Shouldn't Merge
It was formed in 2004 in a merger between two French companies, Sanofi-Synthelabo and Aventis.
FORBES: Forget Aventis
Analysts generally expect Bristol and Sanofi-Synthelabo , which developed Plavix, to triumph, but they've been wrong before.
FORBES: The 'Buy' Case For Bristol-Myers
应用推荐
模块上移
模块下移
不移动